Patient-Reported Reasons for the Discontinuation of Commonly Used Treatments for Moderate to Severe Psoriasis

Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2012.06.035
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Elsevier BV

Related search

541 Evaluation of Optimal Psoriasis Assessment Tool (OPAT) Incorporating Both Clinical and Patient-Reported Outcomes for Treatment of Moderate-To-Severe Plaque Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Psy84 - Impact of High Discontinuation Rates for Secukinumab on Average Costs and Cost-Effectiveness Relative to Other Biological Treatments of Moderate-To-Severe Plaque Psoriasis in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy29 - Real-World Discontinuation of Biological Treatments in Moderate-To-Severe Plaque Psoriasis Over the First 5 Years of Treatment – A Literature Review of Drug Survival

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparability of Trial Populations in Network Meta-Analyses Assessing Biologic Treatments in Moderate to Severe Plaque Psoriasis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

712: Validity of Commonly Used Screening Criteria for Severe Maternal Morbidity

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2019English

Pss32 - Cost-Effectiveness of Brodalumab for the Treatment of Moderate to Severe Plaque Psoriasis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy149 - Iqvia Patient Data Assessment: Real World Evidence in the Management of Moderate-To-Severe Plaque Psoriasis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PSS14 Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy